Global Anti Neurofilament L Antibody Industry is expected to reach new heights, with a robust 11% CAGR driving a stunning US$ 457 Billion valuation by 2032 | FMI
In a new revelation, the Global Anti-Neurofilament L Antibody Industry emerges as a beacon of transformative